MORE Savings Act
This bill eliminates copays and deductibles for opioid treatment under Medicare, requires private health insurance plans to cover opioid medications and related services without cost-sharing starting in 2025, and increases federal Medicaid funding for medication-assisted treatment. It directly affects Medicare beneficiaries, Medicaid patients, and individuals with private health insurance by removing financial barriers to evidence-based treatments. Key provisions include a 5-year Medicare pilot in 15 states meeting specific criteria (high opioid deaths, rural areas, and Medicare enrollment), mandatory coverage for prescription drugs, behavioral health services, and recovery support like peer counseling and transportation, and a 90% federal Medicaid match for these services. The bill applies to all three insurance systems but takes effect earliest for private plans in 2025.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2023
Committee Review
Floor Vote
President
Introduced Mar 17, 2023
Last action Mar 24, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Mar 24, 2023
Committee
Referred to the Subcommittee on Health.
lower
Mar 17, 2023
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Mar 17, 2023
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 1620
Scope: US
Hi! I can help you understand HR 1620. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline